Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.
about
Human recombinant activated protein C for severe sepsisHuman recombinant protein C for severe sepsis and septic shock in adult and paediatric patientsHuman recombinant activated protein C for severe sepsisClinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis.Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?Differential cytokine gene expression according to outcome in a hamster model of leptospirosis.Direct, rapid antimicrobial susceptibility test from positive blood cultures based on microscopic imaging analysis.Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study.Weighted-incidence syndromic combination antibiograms to guide empiric treatment of critical care infections: a retrospective cohort study.Does HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia?Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis.Genetic variation in the TNF gene is associated with susceptibility to severe sepsis, but not with mortalityAn extracorporeal blood-cleansing device for sepsis therapy.Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.Micromagnetic-microfluidic blood cleansing device.Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsisThe role and source of tumor necrosis factor-α in hemorrhage-induced priming for septic lung injury.Association of tumor necrosis factor β genetic polymorphism and sepsis susceptibilityThe importance of fever as a predictive symptom for the potency of host's monocytes to release pro- and anti-inflammatory mediatorsAntimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosisThe duration of SIRS before organ failure is a significant prognostic factor of sepsis.Duplex DNA-Invading γ-Modified Peptide Nucleic Acids Enable Rapid Identification of Bloodstream Infections in Whole Blood.The genetics of acute lung injury: looking back and pointing the way forwardRapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis.Association of Delayed Antimicrobial Therapy with One-Year Mortality in Pediatric Sepsis.Rapid separation of very low concentrations of bacteria from blood.Pharmacokinetics and Pharmacodynamics of Extended Infusion Versus Short Infusion Piperacillin-Tazobactam in Critically Ill Patients Undergoing CRRT.Detection and validation of volatile metabolic patterns over different strains of two human pathogenic bacteria during their growth in a complex medium using multi-capillary column-ion mobility spectrometry (MCC-IMS)Vision Marker-Based In Situ Examination of Bacterial Growth in Liquid Culture Media.Tumor necrosis factor-α -308G/A and -238G/A polymorphisms are associated with increased risks of sepsis: evidence from an updated meta-analysis.Light Emitting Marker for Robust Vision-Based On-The-Spot Bacterial Growth Detection.Neonatal infections in Saudi Arabia: Association with cytokine gene polymorphisms.Association between interleukin-10 polymorphisms and sepsis: a meta-analysis.An empiric antibiotic protocol using risk stratification improves antibiotic selection and timing in critically ill children.Association between lymphotoxin-α intron +252 polymorphism and sepsis: a meta-analysis.Tumor necrosis factor-α -308 G/A polymorphism and risk of sepsis, septic shock, and mortality: an updated meta-analysis.Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures.
P2860
Q24201123-0F89CEA0-B264-4A9B-8625-60A883FA735AQ24202128-2681E9E8-C98F-4A28-9E85-E233A99C8B6AQ24235181-DE4CC12F-A648-4D56-995F-6C43E83C9253Q30908704-CC290260-141F-49EE-A475-54F3EE503AEDQ33517601-10D01591-EE4D-4A71-99B5-16AC3DEB2A06Q33524409-DB3FC9E7-99DF-4FB9-B416-7F5EBDEE77CAQ33682185-3E00E811-9867-41C2-9267-06A21944DD29Q33754099-22163E4F-26A9-4C2D-AA3D-7385D58848C5Q33821913-56AFE65D-EDEF-4D7A-AB56-ED315BFCB03FQ34321144-F3455663-2585-4AAF-AEB0-DFD969A6D338Q34424217-AB19FC87-8BA0-448C-89B3-FDB7D8EBA7FDQ34430827-AA754F20-6388-4DB6-B8F0-06194ED69C32Q34438255-46FC9745-7D78-46F1-874C-8673155B487EQ34529198-BEB0753C-EF07-47DE-9EC3-C69112AAC478Q34976007-04F3D003-0510-4B65-9C97-B42583800B16Q35663183-24A5AF1D-D0C9-40F5-9A6B-951580CF9E56Q35973583-0C34E6FB-D374-43CA-B61A-D37ECAD739CCQ36230486-A3B0999F-45B5-4224-ACF9-4DA13BEBAFF6Q36513681-D8967D3C-F352-4A92-AA0F-A30FDFC631A3Q36566861-249BFA3D-59A5-44F3-ABAD-E883B86717F0Q36687217-4E2E2A89-4551-443F-86D4-1066965EE45CQ36849914-CC3DC7E4-63AC-4C9B-9854-ECA67D20ED4DQ37381875-954716F5-318F-4A5F-B5E9-76E7DB225FC6Q37489932-DB075A8A-0C53-4CFE-A34A-655C0D6F306DQ37563029-C95329C3-367B-45A5-8354-8677688E9CA0Q37781944-E4109DA5-82F3-47A4-8E04-D574115C8620Q38110235-A6F077EE-BA02-49C8-85E9-C165EBE66C39Q38766827-5AD367FC-B8E7-4DCD-84C2-4B77485F6A84Q38791100-938AD143-E8FC-4EDD-B44E-78A29563CB5DQ38838763-897E0196-985E-4800-AF40-0EFA88BE315BQ39579659-7E5C521F-AFD8-45FB-BEDD-DD09B97C2DAFQ40010059-E428D18E-4090-42DD-89E4-4395046C1143Q40292042-53990200-577B-48F7-B7A4-67E5E88ADAB1Q40480173-B60C45FF-F0EA-47C7-82D1-DEEA914D2AC1Q41118096-E5F21882-E8AA-422E-BE37-59399B949C42Q41604538-4137A41E-0C3C-4E26-AFBB-EE5D629CF1B5Q41658548-FA7FBDFC-D817-4B42-BB87-E7D7102025D9Q45303230-82FC31E9-FA87-4E1F-9692-8F719CF6DA13Q47093883-8C738A28-7CCE-4BBC-953B-A1D5FA86687BQ48326485-194F5AA5-31F2-4735-B9CF-BD2CD9149E22
P2860
Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Timing of adequate antibiotic ...... hisms in patients with sepsis.
@ast
Timing of adequate antibiotic ...... hisms in patients with sepsis.
@en
type
label
Timing of adequate antibiotic ...... hisms in patients with sepsis.
@ast
Timing of adequate antibiotic ...... hisms in patients with sepsis.
@en
prefLabel
Timing of adequate antibiotic ...... hisms in patients with sepsis.
@ast
Timing of adequate antibiotic ...... hisms in patients with sepsis.
@en
P2093
P2860
P50
P356
P1433
P1476
Timing of adequate antibiotic ...... hisms in patients with sepsis.
@en
P2093
Carlos Ortiz-Leyba
Carmen Garnacho-Montero
Rocio Jiménez
Teresa Aldabo-Pallas
P2860
P2888
P356
10.1186/CC4995
P577
2006-01-01T00:00:00Z
P5875
P6179
1002319592